Our data clearly demonstrated that IL-10-treated adipose stromal cells could be used to alleviate liver glucose gluconeogenesis, insulin resistance, and DPP4 activity in a mouse model of T2DM. Here, IL10 is linked to type 2 diabetes mellitus.